• Carvedilol Phosphate: Optimizing Non-Selective Beta Blocker

  2026-08-04

  Carvedilol Phosphate empowers researchers to model ischemia–reperfusion injury with high reproducibility and mechanistic clarity, especially in cardiovascular and liver injury studies. Its solubility and purity make it uniquely suited for advanced workflows investigating macrophage polarization and GPCR signaling.

• 2',7'-Dichlorofluorescein Diacetate: Next-Gen ROS Quantifica

  2026-08-03

  Explore how 2',7'-Dichlorofluorescein diacetate enables next-level, quantitative detection of reactive oxygen species (ROS) within complex tumor microenvironments. This article provides advanced insights linking probe chemistry to innovative nanomedicine applications, setting it apart from standard intracellular ROS assay guides.

• DOT1L Inhibition Enhances Lenalidomide Response in Myeloma

  2026-08-03

  This study demonstrates that inhibiting the epigenetic regulator DOT1L reprograms innate immunity in multiple myeloma (MM) cells, thereby amplifying the anti-myeloma effects of immunomodulatory drugs such as lenalidomide. The findings provide a mechanistic rationale for combinatorial approaches targeting DOT1L and highlight new strategies for overcoming resistance and boosting immune activation in MM research.

• Neurotensin (CAS 39379-15-2): Precision Tools for GPCR & miR

  2026-08-02

  Explore how Neurotensin, a potent Neurotensin receptor 1 activator, enables precision studies of GPCR trafficking and miRNA regulation in gastrointestinal physiology. This article uniquely addresses assay interference and spectral fidelity, advancing rigor in biomedical research.

• Vorinostat (SAHA): Epigenetic Modulation, PDAR, and Assay In

  2026-08-01

  Explore how Vorinostat (SAHA, MK0683) advances cancer biology through precision epigenetic modulation and activation of apoptotic pathways. This article uniquely integrates mechanistic insights with the latest research on RNA Pol II-driven cell death, providing actionable guidance for experimental oncology.

• Complete Nicotine Biosynthesis: Mechanisms, Metabolon Assemb

  2026-07-31

  Chang et al. (2026) achieved the first full reconstruction of nicotine biosynthesis in plants, revealing a five-component membrane-bound metabolon that orchestrates the final stereoselective coupling, glycosylation, and transport steps. This breakthrough clarifies longstanding gaps in alkaloid biosynthesis and opens avenues for metabolic engineering and pest resistance strategies.

• Fulvestrant (ICI 182,780): Experimental Workflows & Innovati

  2026-07-31

  Fulvestrant (ICI 182,780) is a gold-standard estrogen receptor antagonist, uniquely enabling post-translational MDM2 degradation and chemosensitization in breast cancer research. This guide details actionable experimental workflows, troubleshooting strategies, and translational insights for maximizing reproducibility and impact.

• Capsaicin as a Translational Probe: TRPV1, KDM1A, and Beyond

  2026-07-30

  Explore the dual mechanistic power of (E)-Capsaicin in activating TRPV1 and inhibiting KDM1A/LSD1, and discover strategic guidance for translational researchers seeking high-reproducibility workflows in pain, inflammation, and cancer epigenetics studies. This article bridges mechanistic insights with actionable protocol design, competitive benchmarking, and future-facing translational opportunities—escalating the discussion beyond typical product resources.

• Plk1 Regulation of p31comet in Mitotic Checkpoint Disassembl

  2026-07-30

  This study elucidates how Polo-like kinase 1 (Plk1) modulates the activity of p31comet during the disassembly of mitotic checkpoint complexes (MCC). By revealing that Plk1-driven phosphorylation suppresses p31comet function, the research clarifies a critical control point in chromosome segregation fidelity and offers mechanistic insight into mitotic checkpoint regulation.

• Targeting Cdc42 to Mitigate Kidney Fibrosis: New Insights

  2026-07-29

  A recent study identified daphnepedunin A as a natural Cdc42 inhibitor that suppresses kidney fibrosis by disrupting the GSK-3β/β-catenin pathway. These findings position Cdc42 as a promising therapeutic target and provide a mechanistic rationale for using selective Cdc42 inhibitors in renal fibrosis research.

• Recombinant Mouse IFN-γ: Unlocking Antigen Presentation in M

  2026-07-29

  Explore how Recombinant Mouse IFN-γ (E.coli, His & Strep, Liquid) advances antigen presentation research in MASH-HCC. Delve into mechanistic insights and optimized assay strategies for robust immunomodulatory cytokine studies.

• Haloprogin: Broad-Spectrum Antifungal and Antimicrobial Insi

  2026-07-28

  The 1970 study by Harrison et al. established Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene) as a potent topical antifungal and selective antimicrobial agent. Its robust efficacy against dermatophytes, Candida species, and Gram-positive bacteria in both in vitro and in vivo models has informed modern infection research and protocol development.

• Busulfan: DNA Alkylating Agent for Senescence & Germ Cell Mo

  2026-07-28

  Busulfan is a DNA alkylating agent essential for modeling cellular senescence and germ cell depletion in both in vitro and in vivo systems. This article details cutting-edge workflows, protocol refinements, and troubleshooting strategies, all rooted in recent dual recombinase-mediated lineage tracing breakthroughs and the robust reliability of APExBIO-supplied Busulfan.

• Cytoskeleton-Dependent Autophagy Triggered by Mechanical Str

  2026-07-27

  This study reveals that mechanical stress-induced autophagy in human cells depends critically on the cytoskeleton, particularly microfilaments. The findings clarify how cytoskeletal integrity governs mechanotransduction and autophagic signaling, providing mechanistic insight for cell biology and cancer research.

• LGK-974: Deep Mechanistic Insights and Assay Design for Wnt

  2026-07-27

  Explore how LGK-974, a potent PORCN inhibitor, enables precise Wnt pathway manipulation in advanced cancer research. This article provides unique mechanistic insights, practical assay guidance, and a critical analysis of recent breakthroughs in pancreatic cancer models.

450 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page